Impact Factor
3.67
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.45
1,390 total citations
h5-index
46
h5 depth signal
Cited share
65.8%
279 of 424
Total citations
1,390
Citation footprint
Metric signal
3.66
External metric anchor
Self-citation
13.3%
185 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,322
Italy
134
Canada
126
United Kingdom
112
China
96
Citing Fields of Research
Migraines & Headaches
1,914
Vascular Disorders
96
Anesthetic & Pain Medicine
82
Brain Neurological Disorders
76
Nervous System Disorders
72
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
9,737
Articles tracked across the journal lifetime
Indexed publication set
424
279 cited publications
Last 12 months
258
21.5 publications/month
Open access share
36.8%
95 OA publications in the last year
Leading citing country
United States
1,322 citing publications
Leading citing field
Migraines & Headaches
1,914 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v5n3,Oct. 1965-
v5n3,Oct. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Migraines & Headaches
Issuing & Sponsoring Bodies
Contributor
American Association for the Study of Headache
Contributor
American Headache Society
Broad Categories
Neurology
Psychophysiology
Migraines & Headaches
MeSH Descriptors
Headache
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/head.70220
Open DOI
Subspecialty headache clinic visit reduced healthcare utilization in patients with migraine: Single institution retrospective cohort study
Objective: This study aimed to evaluate whether care in a subspecialty headache center, compared with a general neurology clinic, was associated with lower 90‐day unplanned healthcare utilization (HCU) in patients with migraine and to id...
02
DOI 10.1111/head.70193
Open DOI
Plasma amylin levels in migraine and after erenumab treatment: A REFORM study
Objective: To investigate whether plasma amylin concentrations differ between adults with migraine and healthy controls (HCs) and whether baseline or longitudinal amylin levels are associated with treatment response to erenumab. Backgrou...
03
DOI 10.1111/head.70244
Open DOI
The MIND study: Design, feasibility, and baseline characteristics of a smartphone‐based migraine cohort
Objectives/Background: Our objective was to describe the design, feasibility, and baseline characteristics of the Migraine Impact on Neurocognitive Dynamics study, a 30‐day smartphone‐based, prospective, decentralized, observational coho...
04
DOI 10.1111/head.70235
Open DOI
Headache disorders among Indigenous communities: A scoping review undertaken with knowledge keeper guidance
Objective: We performed a scoping review of literature on headache etiology, classification, prevalence, and treatment in Indigenous communities in Canada, the United States, Australia, and New Zealand. Background: In the United States, ...
05
DOI 10.1111/head.70241
Open DOI
Opioid use, disability, and patient‐reported cognitive impairment in migraine: Multi‐country results from the Chronic Migraine Epidemiology and Outcomes—International Study
Objective: To characterize the population who do and do not use opioids to treat migraine in the Chronic Migraine Epidemiology and Outcomes–International (CaMEO‐I) Study. Background: Opioids are not recommended for migraine treatment bec...
06
DOI 10.1111/head.70242
Open DOI
Pregnancy outcomes following exposure to galcanezumab: Analysis of cases from the galcanezumab clinical trials and postmarketing database
Objective: This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. Background: Galcanezumab is a calcitonin gene‐related ...
07
DOI 10.1111/head.70208
Open DOI
Perceived headache responses to exercise in patients with migraine: A cross‐sectional study
Objective: To characterize patient‐perceived headache responses to exercise in migraine and to identify associated clinical factors using a large‐scale registry. Background: Regular exercise is often recommended for patients with migrain...
08
DOI 10.1111/head.70246
Open DOI
Issue Information
09
DOI 10.1111/head.70239
Open DOI
Taking the LEAD in headache advocacy: Focus on migraine at school
10
DOI 10.1111/head.70221
Open DOI
Headache among patients undergoing cardiac stress testing: Prevalence, clinical characteristics, and identification of myocardial ischemia
Background: Cardiac cephalalgia is an uncommon secondary headache disorder caused by myocardial ischemia and may occur with or without typical anginal symptoms. Most available literature consists of isolated case reports, and data regard...
Bibliographical & Catalog Notes
Also issued online.
Official publication of the American Association for the Study of Headache, 1961-1999; American Headache Society, 2000-
Vol. 23, no. 1 (JAN 1983)19900914 Notice published Printed on acid-free paper